Authors: Janssens, RMJ Brus, L Cahill, DJ Huirne, JAF Schoemaker, J Lambalk, CB

Citation: Rmj. Janssens et al., Direct ovarian effects and safety aspects of GnRH agonists and antagonists, HUM REP UPD, 6(5), 2000, pp. 505-518

Authors: Janssens, RMJ Lambalk, CB Vermeiden, JPW Schats, R Schoemaker, J

Citation: Rmj. Janssens et al., In-vitro fertilization in a spontaneous cycle: easy, cheap and realistic, HUM REPR, 15(2), 2000, pp. 314-318

Authors: Janssens, RMJ Lambalk, CB Vermeiden, JPW Schats, R Bernards, JM Rekers-Mombarg, LTM Schoemaker, J

Citation: Rmj. Janssens et al., Dose-finding study of triptorelin acetate for prevention of a premature LHsurge in IVF: a prospective, randomized, double-blind, placebo-controlled study, HUM REPR, 15(11), 2000, pp. 2333-2340

Authors: Janssens, RMJ Lambalk, CB Schats, R Schoemaker, J

Citation: Rmj. Janssens et al., Successful in-vitro fertilization in a natural cycle after four previouslyfailed attempts in stimulated cycles, HUM REPR, 14(10), 1999, pp. 2497-2498

Authors: Janssens, RMJ Vermeiden, JPW Lambalk, CB Schats, R Schoemaker, J

Citation: Rmj. Janssens et al., Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled ovarian hyperstimulation in IVF, HUM REPR, 13(9), 1998, pp. 2386-2391

Authors: Janssens, RMJ Dekkers, WJM Gordin, B

Citation: Rmj. Janssens et al., The 11th Annual Conference of the European Society for Philosophy of Medicine and Health Care (ESPMH), J VALUE INQ, 32(4), 1998, pp. 559-564